DRKS00025890尚未招募未知
Multicenter, prospective, randomized study comparing motorized spiral enteroscopy with double balloon enteroscopy
Medizinische Klinik 1 Universitätsmedizin Frankfurt0 个研究点目标入组 32 人开始时间: 2021年7月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •Clinical indication for performing a small bowel eteroscopy
- •signed declaration of consent
排除标准
- •Exclusion criteria
- •Medical instability preventing anesthesia
- •No possibility of obtaining consent
- •Known perforation
- •Uncontrolled coagulopathy
- •Recent nutritional jejunostomy (e.g., less than two weeks ago)
- •Pediatric patients, especially infants and young children
- •Patients who have had a stent or other element implanted in the intestinal tract that could obstruct the passage of the PowerSpiral disposable overtube.
- •With antegrade access
- •Perforated ulcer
- •Esophageal or gastric varices
- •Stenosis in the foregut region
- •Deep laceration of the mucosa
- •Suspected or diagnosed eosinophilic esophagitis
- •Inability to tolerate a mouthpiece
- •With retrograde access
- •Severe active inflammation of the colon
- •Anal stenosis
- •Colon structure
- •Planned enteroscopy with the aim of ERCP after previous surgery
研究者
相似试验
进行中（未招募）
1 期
INTOReTAK : INfliximab and TOcilizumab in Refractory/relapsing TAKayasu arteritisPatients with refractory or relapsing Takayasu Arteritis deseaseEUCTR2018-003753-13-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS50
招募中
不适用
Comparative study between Diode Laser Surgery and Filtering Surgery as a Primary Surgical Procedure for patients with GlaucomaOpen Angle GlaucomaC11.525.381C11.525.381.407RBR-65rzrvCentro de Referência em Oftalmologia da Universidade Federal de Goiás (CEROF-UFG)
进行中（未招募）
不适用
A trial in which will be studied if the addition of a medicine that is used for improving platelet counts (eltrombopag) to the regular treatment for aplastic anemia (hATG + CsA) also improves the numbers of other cell lines and therefore the overall bone marrow function.Idiopathic (Severe) Aplastic Anemia, a bone marrow failure syndrome which results in the normal hematopoietic tissue completely missing from the bone marrow, accounting for the subsequent pancytopenia.MedDRA version: 18.0Level: PTClassification code 10002967Term: Aplastic anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2014-000363-40-ESEuropean Society for Blood and Marrow Transplantation200
进行中（未招募）
1 期
A trial in which will be studied if the addition of a medicine that is used for improving platelet counts (eltrombopag) to the regular treatment for aplastic anemia (hATG + CsA) also improves the numbers of other cell lines and therefore the overall bone marrow function.Idiopathic (Severe) Aplastic Anemia, a bone marrow failure syndrome which results in the normal hematopoietic tissue completely missing from the bone marrow, accounting for the subsequent pancytopenia.MedDRA version: 19.0Level: PTClassification code 10002967Term: Aplastic anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2014-000363-40-NLEuropean Society for Blood and Marrow Transplantation200
已完成
3 期
A prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for severe aplastic anemia patients.10018849panmyelopathybonemarrow failureNL-OMON44180European society for Blood and Marrow Transplantation48